Kentucky Heart Foundation Inc
Nonprofit profile at a glance
- EIN
- 260791997
- IRS 990 coverage
- 2010–2024
- Forms available
- Form 990 2024, Form 990-EZ 2009
- Location
- Ashland, KY, USA
- Phone
- 6063241544
- Rating
- 74
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Heart, Circulatory Research
Reported finances
- Revenue
- $735
- Expenses
- $115,381
- Assets
- $570,165
- Liabilities
- $0
Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
16 people listed
Executive titles in this filing
- SARA MARKS (PRESIDENT/CEO)
- PATRICIA CORBITT (EXECUTIVE DIRECTOR KHF)
Highest reported compensation
- SARA MARKS (PRESIDENT/CEO): $1,196,109 total reported compensation
- AUTUMN MCFANN (TREASURER): $1,155,483 total reported compensation
- CHARBEL SALEM (KHF MEDICAL DIRECTOR, PHYSICIAN): $1,044,180 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To reduce the impact of heart and vascular disease through research, prevention, and education. Vision: to improve the quality of life by reducing the devastating impact of cardiovascular disease.
What it reported doing in 2024
Form 990, part iii, line 4a: the Kentucky heart foundation (khf) was founded in may 2007. The khf is a nonprofit organization that works with other healthcare providers to address heart and vascular disease in this region. In conjunction with these other providers the khf works on the following:-improving the quality of life in the appalachian region-reducing the devastating impact of cardiovascular disease-advancing medical science through integrated, innovative and progressive programs in research, education, prevention, early detection, and improved patient care-creating access to cutting-edge technology -developing a forum for research that will benefit patients throughout the nationkhf's vision is to improve the quality of life by reducing the devastating impact of cardiovascular disease. Our mission is to reduce the impact of heart and vascular disease through research, prevention and education. Priorities include: research, education, prevention, finance, and culture.the khf serves appalachian counties covering parts of eastern Kentucky, southeastern Ohio and western West Virginia. These counties are some of the most impoverished in the area. Also known as the coronary valley, the area got this name because of the high mortality rates from cardiovascular disease and the poor health habits of its residents. Heart disease is the number one killer of adults, with mortality rates very high compared to state and national data. Residents of the area have low academic achievement; high smoking rates; lack of physical exercise; and one of the highest obesity rates in the nation. All combined, it is no wonder that cardiovascular disease is the number one health threat for adults in the area. With a focus on improving the cardiovascular outcomes for the area's residents. Partnering with progressive cardiologists, cardiothoracic surgeons, vascular surgeons, and interventional radiologists at king's daughters provides the khf the opportunity to answer important clinical research questions in order to improve care for our patients for now and generations to come.the khf works with device and drug manufacturers to bring new research programs to the region. Khf has been and continues to be focused on research to improve the assessment, prevention, and treatment of acute coronary syndrome, myocardial infarction, dual antiplatelet therapy, atrial fibrillation, heart failure, stroke and vascular disease, childhood and adult obesity, and lung health. The khf has also expanded this fy2025 to include some preventative education and research focused on colorectal screenings and diabetes. The khf has three primary program-related focused areas: research, education, and prevention. 1) research: during fy2025, the khf continued to focus on research by participating in active clinical trials and public health research projects in partnership with uk college of public health. Clinical trials:-wave: prospective, randomized, controlled, multicenter study comparing the merit wrapsody endovascular stent graft to percutaneous transluminal angioplasty for treatment of venous outflow circuit stenosis or occlusion in hemodialysis patients.precision public health alliance:-the impact award project: an innovative partnership serving appalachian northeastern Kentucky through a collaboration between the uk college of public health, king's daughters, and local social services, behavioral health, and public safety agencies to examine the interplay between social and clinical factors that underpin population health challenges specific to this rural region. -centers for disease control grant - quality improvement project to address community-clinical linkages for patient with diabetes. Through a collaboration with kyrec and khf working to identify ways to ensure that patients with diabetes and unmet social determinate of health needs are having their needs met by connecting them with the appropriate community resource. The foundation continually looks for trials
Operating model
- Revenue model
- Investment-supported. 100% of the money available for current operations came from recurring investment income.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and most voting board members are independent. Few specific pay-setting methods are documented in the filing; unanswered boxes are not proof of absence and expenses are high relative to revenue.
Rating breakdown
- Financial Efficiency: 89
- Transparency & Controls: 60
- Accountability: 95
- Sustainability: 23
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 100%; rating input score 100
- Program expense ratio: 99.9%; rating input score 100
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
- Pay-setting controls: 0 of 6 controls in place; rating input score 0
- Compensation committee: Missing
- Independent consultant: Missing
- Other Form 990s reviewed: Missing
- Written employment contract: Missing
- Compensation survey or study: Missing
- Board or committee approval: Missing
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Limited
- Related-party transparency: Limited
Accountability
- Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
- Governance controls: 8 of 9 controls in place; rating input score 89
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: Pass
- Other executive compensation review process: Pass
- Form 990 shared with the board: Fail
- Board meeting minutes documented: Pass
- Audit committee oversight: Pass
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: -15,598.1%; rating input score 1; 1st percentile among comparable filings
- Total-asset coverage ratio: 4.94; rating input score 49; 49th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 69; 69th percentile among comparable filings
- Officer compensation ratio: 391.3%; rating input score 2; 2nd percentile among comparable filings
Growth
- Program expense growth: -14.7% per year; rating input score 0; 22nd percentile among comparable filings
- Revenue growth: -21.7% per year; rating input score 0; 18th percentile among comparable filings
- Asset growth: -0.3% per year; rating input score 0; 38th percentile among comparable filings
Details
- Where the money goes: 100% of revenue deployed · 99.9% of spending went to programs
- Governance: 10 of 10 board members independent · 8 of 9 filing controls reported
- Programs: 1 filed program accomplishment · $115K in reported program spending
- Leadership: top reported pay $1.2M · 16 people listed · 0 of 6 pay-setting controls reported
- Consistency: 14 of 14 current checks pass
- Schedules: 5 filed schedules · includes executive pay
- Filing history: 15 filing years from 2010 to 2024
- Contacts: How to reach this organization
- Money network: 2 filed money-flow records
- Related organizations: 9 filed related-organization links
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Transparency & Controls: Pay-setting controls scored 0/100.
- High — Sustainability: Operating margin scored 1/100.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Growth: Asset growth scored 0/100.
- Review — Accountability: Governance controls: Form 990 shared with the board not reported.
- Moderate — Sustainability: Total-asset coverage ratio scored 49/100.
- High — Sustainability: Officer compensation ratio scored 2/100.